Why biotherapeutics Is Trending Today?

Explore key developments that caused biotherapeutics to trend — updated as the story unfolds.

2 key events detected

July 15, 2025 at 5:40 PM

Sonnet Biotherapeutics (NASDAQ: SONN) is under investigation for potential M&A-related issues, following a rebrand, and is among five stocks, including Palantir, The Trade Desk, Tilray, and Tesla, currently in focus for investors.

July 14, 2025 at 5:11 PM

Sonnet BioTherapeutics, a public biotech firm, is merging with Rorschach I LLC in an $888 million deal to launch Hyperliquid Strategies and create a $583 million HYPE token reserve, sending its stock soaring over 218%.